Company Filing History:
Years Active: 2013-2014
Title: Haizhou Sun: Innovator in Anti-Cancer Therapeutics
Introduction
Haizhou Sun is a prominent inventor based in Dallas, TX (US), known for his significant contributions to the field of pharmaceuticals. He holds two patents that focus on innovative anti-cancer agents, showcasing his commitment to advancing medical science.
Latest Patents
Sun's latest patents include "Smac mimetic dimers and trimers useful as anti-cancer agents" and "Dimeric Smac mimetics." The first invention provides small molecule mimics of the Smac peptide that are dimer-like or trimer-like compounds. These compounds have two or three amide-containing domains connected by a linker, which are useful in promoting apoptosis. The invention also includes pharmaceutical compositions comprising such compounds and methods to use them to treat conditions including cancer and autoimmune disorders. The second patent focuses on small molecule mimics of the Smac peptide that are dimers or dimer-like compounds with two binding domains connected by a linker. Similar to the first, these compounds are designed to promote apoptosis and include pharmaceutical compositions for treating cancer and autoimmune disorders.
Career Highlights
Haizhou Sun is currently associated with Joyant Pharmaceuticals, Inc., where he continues to work on groundbreaking research in the pharmaceutical industry. His innovative approach and dedication to developing effective treatments have made him a valuable asset in the field.
Collaborations
Sun collaborates with notable colleagues, including Gunnar J. Hanson and Xiaoming Xu, who contribute to his research efforts and the advancement of their shared goals in pharmaceutical innovation.
Conclusion
Haizhou Sun's work in developing anti-cancer agents through innovative patents highlights his significant role in the pharmaceutical industry. His contributions are paving the way for new therapeutic options in the fight against cancer and autoimmune disorders.